Koers SpectraCure AB (publ) Nasdaq Stockholm
Aandelen
SE0007158118
Geavanceerde medische apparatuur & technologie
Omzet 2022 | - | Omzet 2023 | 318K 29,1K 27,16K | Marktkapitalisatie | 375 mln. 34,31 mln. 32,02 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -25 mln. -2,29 mln. -2,14 mln. | Nettowinst (verlies) 2023 | -20 mln. -1,83 mln. -1,71 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 90,48 mln. 8,28 mln. 7,73 mln. | Nettoliquiditeiten 2023 | 50,23 mln. 4,6 mln. 4,29 mln. | EV/omzet 2023 | 1.021 x |
K/w-verhouding 2022 |
-19,2
x | K/w-verhouding 2023 |
-18,3
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 77,13% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Masoud Khayyami
CEO | Chief Executive Officer | 61 | 07-01-10 |
Henrik Ljung
DFI | Director of Finance/CFO | 66 | 01-04-18 |
Kristina Holst
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 79 | 01-03-03 | |
Thomas Kramar
BRD | Director/Board Member | 70 | 01-01-22 |
Masoud Khayyami
CEO | Chief Executive Officer | 61 | 07-01-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,04% | 220 mln. | |
-27,57% | 83,47 mln. |